CLAY B SIEGALL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
Latest Insider Trading Transactions of CLAY B SIEGALL
Sentiment: All, ALDR, SGEN, SYBX, RARE
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.32 | 7,632 | 384,042 | 687,146 | 694.8 K to 687.1 K (-1.10 %) |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 7,632 | 84,639 | 694,778 | 687.1 K to 694.8 K (+1.11 %) |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 50.98 | 800 | 40,784 | 687,146 | 687.9 K to 687.1 K (-0.12 %) |
| Feb 13 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 800 | 8,872 | 687,946 | 687.1 K to 687.9 K (+0.12 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 700 | 7,763 | 131,823 | |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 7,562 | 83,863 | 132,523 | |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 10,570 | 117,221 | 140,085 | |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 52.95 | 700 | 37,065 | 687,146 | 687.8 K to 687.1 K (-0.10 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 700 | 7,763 | 687,846 | 687.1 K to 687.8 K (+0.10 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 51.94 | 7,562 | 392,770 | 687,146 | 694.7 K to 687.1 K (-1.09 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 7,562 | 83,863 | 694,708 | 687.1 K to 694.7 K (+1.10 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 51.47 | 10,570 | 544,038 | 687,146 | 697.7 K to 687.1 K (-1.51 %) |
| Jan 16 2018 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 10,570 | 117,221 | 697,716 | 687.1 K to 697.7 K (+1.54 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,800 | 19,962 | 150,655 | |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 2,300 | 25,507 | 152,455 | |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 11,787 | 130,718 | 154,755 | |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 2,945 | 32,660 | 166,542 | |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 53.62 | 1,800 | 96,516 | 687,146 | 688.9 K to 687.1 K (-0.26 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,800 | 19,962 | 688,946 | 687.1 K to 688.9 K (+0.26 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 54.67 | 2,300 | 125,741 | 687,146 | 689.4 K to 687.1 K (-0.33 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 2,300 | 25,507 | 689,446 | 687.1 K to 689.4 K (+0.33 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.57 | 11,787 | 655,004 | 687,146 | 698.9 K to 687.1 K (-1.69 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 11,787 | 130,718 | 698,933 | 687.1 K to 698.9 K (+1.72 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 56.39 | 2,945 | 166,069 | 687,146 | 690.1 K to 687.1 K (-0.43 %) |
| Dec 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 2,945 | 32,660 | 690,091 | 687.1 K to 690.1 K (+0.43 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 17,109 | 189,739 | 169,487 | |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,723 | 19,108 | 186,596 | |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.95 | 17,109 | 991,467 | 687,146 | 704.3 K to 687.1 K (-2.43 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 17,109 | 189,739 | 704,255 | 687.1 K to 704.3 K (+2.49 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 58.46 | 1,723 | 100,727 | 687,146 | 688.9 K to 687.1 K (-0.25 %) |
| Nov 14 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,723 | 19,108 | 688,869 | 687.1 K to 688.9 K (+0.25 %) |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 0.99 | 9,090 | 8,999 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 1.65 | 9,090 | 14,999 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | M | 1.27 | 9,090 | 11,499 | 0 | |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 0.99 | 9,090 | 8,999 | 31,714 | 22.6 K to 31.7 K (+40.18 %) |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 1.65 | 9,090 | 14,999 | 22,624 | 13.5 K to 22.6 K (+67.16 %) |
| Nov 03 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Buy | M | 1.27 | 9,090 | 11,499 | 13,534 | 4.4 K to 13.5 K (+204.55 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,797 | 19,929 | 188,319 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 837 | 9,282 | 190,116 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,400 | 15,526 | 190,953 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 6,899 | 76,510 | 192,353 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 6,699 | 74,292 | 199,252 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,200 | 13,308 | 205,951 | |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.79 | 1,797 | 103,849 | 687,146 | 688.9 K to 687.1 K (-0.26 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,797 | 19,929 | 688,943 | 687.1 K to 688.9 K (+0.26 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 58.86 | 837 | 49,266 | 687,146 | 688 K to 687.1 K (-0.12 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 837 | 9,282 | 687,983 | 687.1 K to 688 K (+0.12 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 60.37 | 1,400 | 84,518 | 687,146 | 688.5 K to 687.1 K (-0.20 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,400 | 15,526 | 688,546 | 687.1 K to 688.5 K (+0.20 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.33 | 6,899 | 423,116 | 687,146 | 694 K to 687.1 K (-0.99 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 6,899 | 76,510 | 694,045 | 687.1 K to 694 K (+1.00 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.08 | 6,699 | 415,874 | 687,146 | 693.8 K to 687.1 K (-0.97 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 6,699 | 74,292 | 693,845 | 687.1 K to 693.8 K (+0.97 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 63.01 | 1,200 | 75,612 | 687,146 | 688.3 K to 687.1 K (-0.17 %) |
| Oct 13 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,200 | 13,308 | 688,346 | 687.1 K to 688.3 K (+0.17 %) |
| Sep 28 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 9,017 | 99,999 | 0 | |
| Sep 28 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 9,017 | 99,999 | 687,146 | 678.1 K to 687.1 K (+1.33 %) |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 17,117 | 189,828 | 207,151 | |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 11.09 | 1,715 | 19,019 | 224,268 | |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 53.42 | 17,117 | 914,390 | 678,129 | 695.2 K to 678.1 K (-2.46 %) |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 17,117 | 189,828 | 695,246 | 678.1 K to 695.2 K (+2.52 %) |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 54.15 | 1,715 | 92,867 | 678,129 | 679.8 K to 678.1 K (-0.25 %) |
| Sep 12 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 11.09 | 1,715 | 19,019 | 679,844 | 678.1 K to 679.8 K (+0.25 %) |
| Aug 30 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 47.89 | 25,506 | 1,221,597 | 678,129 | 703.6 K to 678.1 K (-3.62 %) |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 46.37 | 165,844 | 7,690,186 | 165,844 | |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 46.37 | 2,156 | 99,974 | 2,156 | |
| Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Grant | A | 0.00 | 67,200 | 0 | 703,635 | 636.4 K to 703.6 K (+10.56 %) |
| Aug 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,413 | 107,150 | 0 | |
| Aug 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 48.91 | 10,413 | 509,300 | 636,435 | 646.8 K to 636.4 K (-1.61 %) |
| Aug 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,413 | 107,150 | 646,848 | 636.4 K to 646.8 K (+1.64 %) |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 8,194 | 84,316 | 10,413 | |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 2,229 | 22,936 | 18,607 | |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 51.86 | 8,194 | 424,941 | 636,435 | 644.6 K to 636.4 K (-1.27 %) |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 8,194 | 84,316 | 644,629 | 636.4 K to 644.6 K (+1.29 %) |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 52.43 | 2,229 | 116,866 | 636,435 | 638.7 K to 636.4 K (-0.35 %) |
| Jul 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 2,229 | 22,936 | 638,664 | 636.4 K to 638.7 K (+0.35 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 9,760 | 100,430 | 20,836 | |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 663 | 6,822 | 30,596 | |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.17 | 9,760 | 636,059 | 636,435 | 646.2 K to 636.4 K (-1.51 %) |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 9,760 | 100,430 | 646,195 | 636.4 K to 646.2 K (+1.53 %) |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.82 | 663 | 43,639 | 636,435 | 637.1 K to 636.4 K (-0.10 %) |
| Jun 07 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 663 | 6,822 | 637,098 | 636.4 K to 637.1 K (+0.10 %) |
| May 26 2017 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 16.90 | 15,000 | 253,500 | 15,000 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 9,330 | 96,006 | 31,259 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 993 | 10,218 | 40,589 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 100 | 1,029 | 41,582 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,039 | 41,198 | 0 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.47 | 4,039 | 248,277 | 636,435 | 640.5 K to 636.4 K (-0.63 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,039 | 41,198 | 640,474 | 636.4 K to 640.5 K (+0.63 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.72 | 9,330 | 575,848 | 636,435 | 645.8 K to 636.4 K (-1.44 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 9,330 | 96,006 | 645,765 | 636.4 K to 645.8 K (+1.47 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.82 | 993 | 62,380 | 636,435 | 637.4 K to 636.4 K (-0.16 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 993 | 10,218 | 637,428 | 636.4 K to 637.4 K (+0.16 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 63.92 | 100 | 6,392 | 636,435 | 636.5 K to 636.4 K (-0.02 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 100 | 1,029 | 636,535 | 636.4 K to 636.5 K (+0.02 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,423 | 107,253 | 41,682 | |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 3,327 | 33,935 | 4,039 | |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 715 | 7,293 | 7,366 | |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.02 | 3,327 | 206,341 | 636,435 | 639.8 K to 636.4 K (-0.52 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 3,327 | 33,935 | 639,762 | 636.4 K to 639.8 K (+0.52 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.93 | 715 | 44,995 | 636,435 | 637.2 K to 636.4 K (-0.11 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 715 | 7,293 | 637,150 | 636.4 K to 637.2 K (+0.11 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 63.30 | 10,423 | 659,776 | 636,435 | 646.9 K to 636.4 K (-1.61 %) |
| Apr 06 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,423 | 107,253 | 646,858 | 636.4 K to 646.9 K (+1.64 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,423 | 107,253 | 52,105 | |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 2,818 | 28,744 | 8,081 | |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 1,224 | 12,485 | 10,899 | |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.65 | 2,818 | 190,638 | 636,435 | 639.3 K to 636.4 K (-0.44 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 2,818 | 28,744 | 639,253 | 636.4 K to 639.3 K (+0.44 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 67.88 | 1,224 | 83,085 | 636,435 | 637.7 K to 636.4 K (-0.19 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 1,224 | 12,485 | 637,659 | 636.4 K to 637.7 K (+0.19 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 68.17 | 10,423 | 710,536 | 636,435 | 646.9 K to 636.4 K (-1.61 %) |
| Mar 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,423 | 107,253 | 646,858 | 636.4 K to 646.9 K (+1.64 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 100 | 1,029 | 62,528 | |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,323 | 106,224 | 62,628 | |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 12,123 | |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.51 | 100 | 6,251 | 636,435 | 636.5 K to 636.4 K (-0.02 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 100 | 1,029 | 636,535 | 636.4 K to 636.5 K (+0.02 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.69 | 10,323 | 636,826 | 636,435 | 646.8 K to 636.4 K (-1.60 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,323 | 106,224 | 646,758 | 636.4 K to 646.8 K (+1.62 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.13 | 4,042 | 247,087 | 636,435 | 640.5 K to 636.4 K (-0.63 %) |
| Feb 08 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 640,477 | 636.4 K to 640.5 K (+0.64 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 8,053 | 82,865 | 72,951 | |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 2,180 | 22,432 | 81,004 | |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 190 | 1,955 | 83,184 | |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 200 | 2,040 | 16,165 | |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 3,842 | 39,188 | 16,365 | |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 55.26 | 200 | 11,052 | 638,835 | 639 K to 638.8 K (-0.03 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 200 | 2,040 | 639,035 | 638.8 K to 639 K (+0.03 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.40 | 3,842 | 220,531 | 638,835 | 642.7 K to 638.8 K (-0.60 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 3,842 | 39,188 | 642,677 | 638.8 K to 642.7 K (+0.60 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 57.89 | 8,053 | 466,188 | 638,835 | 646.9 K to 638.8 K (-1.24 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 8,053 | 82,865 | 646,888 | 638.8 K to 646.9 K (+1.26 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 58.86 | 2,180 | 128,315 | 638,835 | 641 K to 638.8 K (-0.34 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 2,180 | 22,432 | 641,015 | 638.8 K to 641 K (+0.34 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 59.68 | 190 | 11,339 | 638,835 | 639 K to 638.8 K (-0.03 %) |
| Jan 10 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 190 | 1,955 | 639,025 | 638.8 K to 639 K (+0.03 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 10,423 | 107,253 | 83,374 | |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,042 | 41,228 | 20,207 | |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 65.70 | 4,042 | 265,577 | 638,835 | 642.9 K to 638.8 K (-0.63 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,042 | 41,228 | 642,877 | 638.8 K to 642.9 K (+0.63 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 66.35 | 10,423 | 691,568 | 638,835 | 649.3 K to 638.8 K (-1.61 %) |
| Dec 08 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 10,423 | 107,253 | 649,258 | 638.8 K to 649.3 K (+1.63 %) |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 3,310 | 34,060 | 93,797 | |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 7,113 | 73,193 | 97,107 | |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 1,600 | 16,320 | 24,249 | |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 2,442 | 24,908 | 25,849 | |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 58.26 | 3,310 | 192,832 | 638,835 | 642.1 K to 638.8 K (-0.52 %) |